We provide engineered reporter cells covering key innate immune receptors, including TLR2, TLR3, TLR4, TLR5, TLR7, TLR8, and TLR9. This platform enables efficient detection of ligand-induced activation, supporting agonist/antagonist screening, vaccine adjuvant evaluation, and innate immune pathway research. It serves as a standardized tool for drug discovery in infectious diseases, oncology, and autoimmune disorders.
